Aspirin may be tied to age-related macular degeneration, researchers find

Share this article:

Those who take aspirin regularly may be in danger of developing age-related macular degeneration (AMD), researchers in Australia have found.

The researchers followed nearly 2,400 study participants for a decade and a half. After 15 years, 3.7% of the study participants who did not take aspirin regularly had developed neovascular AMD, a severe form of macular degeneration. Among those identified as regular aspirin users, more than double that number – 9.3%– were diagnosed with AMD.

Regular aspirin use was defined as taking the drug at least once a week over the course of a year, researchers said.

While the study results were striking, it's not believed it will change clinical best practices yet. However, “thoughtful clinicians” may want to consider the study results, doctors from Cedars-Sinai Medical Center in Los Angeles said in an invited commentary. Previous studies have also linked aspirin usage to macular degeneration.

The results appear in the online edition of the journal JAMA Internal Medicine.

The findings were published within days of a proposal from the Centers for Medicare & Medicaid Services to expand Medicare coverage for certain forms of AMD. Under the proposal, optical coherence tomography would be covered as a method for assessing treatment response. 

Share this article:

More in News

Bulk of Medicaid to be managed care in two years: Avalere

Bulk of Medicaid to be managed care in ...

More than three-quarters of Medicaid beneficiaries will be enrolled in a managed care plan as of 2016, according to an Avalere Health analysis released Thursday. The numbers reveal that managed ...

Nursing home asked for employee's personal information too often, jury rules

The human resources department of a Maine nursing home did not properly protect a former employee's personal identification information, a jury recently ruled.

Test could confirm sepsis within an hour

Nursing home residents might benefit from a new way of diagnosing and treating sepsis made possible by discoveries out of the University of British Columbia.